Position in CYTK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$777,187
+$169,696 QoQ
Shares Held
9,123
-1.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#279
of 480 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NVWM, LLC holds $2,347,266 across 18 Biotechnology names. CYTK ranks #2 (33.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,518 | $1,408,354 | |
| 2 | CYTK |
Cytokinetics Inc
This page
|
9,123 | $777,187 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
125 | $77,941 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,000 | $26,220 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
416 | $19,568 | |
| 6 | MANE |
Veradermics, Inc
|
111 | $13,646 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
165 | $6,436 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 |
All Filings in CYTK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $777,187 | 9,123 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $607,491 | 9,217 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||